The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions
NCT03631238 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41
Last updated 2018-08-16
Summary
The study evaluates if the relationship between total serum cholesterol is dependent on the total serum homocysteine. Fasting blood samples will taken from participants and two batteries of cognitive scales will be used to asses any cognitive decline.
Conditions
- Hypercholesterolemia
- Cognitive Dysfunction
- Hyperhomocysteinemia
Interventions
- DIAGNOSTIC_TEST
-
Blood sampling for total cholesterol and homocysteine and cognitive assessment by psychometric tests.
all participant are subjected to cognitive assessment by psychometric tests by using the arabic version of Mini Mental State Exam (MMSE) and Memory Assessment Scale (MAS). Blood samples were collected in the morning using 10 mL yellow top (plain) Vacutainer tubes. Lipid profile (triglycerides, low-density lipoprotein (LDL), and high-density lipoprotein (HDL)) were measured by Assiut university labs using Cholesterol Kits and analyzed by COBAS Integra analyzer. Total cholesterol levels were calculated using the sum of the LDL and HDL plus one-fifth of triglyceride levels. Samples of serum homocysteine are collected, centrifuged to separate plasma within 30 minutes after venipuncture and stored in specialized container in the Department of Clinical Pathology at (-20◦C) temperature. Total homocysteine was measured by ELISA technique, Sinogen kits (Research Use Only) and Statfax-2100 microplate analyzer.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Nageh F El Gamal, MD · Assiut University
Eligibility
- Min Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-15
- Primary Completion
- 2018-06-01
- Completion
- 2018-08-01
Countries
- Egypt
Study Locations
More Related Trials
-
Choline and Brain Functioning in Postmenopausal Women
NCT07264257 ·Status: COMPLETED ·Phase: NA
-
A Retrospective Analysis of Cerefolin NAC® in Cognitively Impaired Patients
NCT01594541 ·Status: UNKNOWN
-
Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease
NCT02162251 ·Status: COMPLETED
-
The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment
NCT03369925 ·Status: COMPLETED ·Phase: NA
-
Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
NCT01282619 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers
NCT01461174 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
NCT05681819 ·Status: COMPLETED ·Phase: PHASE1
-
Plasma Hydrogen Sulfide as a Biomarker for Alzheimer's Disease and Related Dementias
NCT05060848 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
NCT02859207 ·Status: COMPLETED ·Phase: PHASE1
-
A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition
NCT01044342 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study Between Alzheimer's and Multi-infarct Dementia
NCT05781139 ·Status: RECRUITING
-
Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
NCT07066826 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury
NCT06337994 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of BrainPhyt, a Microalgae Based Ingredient on Cognitive Function in Healthy Older Subjects
NCT04832412 ·Status: COMPLETED ·Phase: NA
-
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
NCT06199037 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers
NCT00777361 ·Status: TERMINATED ·Phase: PHASE1
-
Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer
NCT02553928 ·Status: COMPLETED ·Phase: PHASE4
-
Huperzine A in Alzheimer's Disease
NCT00083590 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
NCT00013923 ·Status: COMPLETED ·Phase: PHASE2
-
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia
NCT04522739 ·Status: COMPLETED ·Phase: PHASE4
-
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
NCT06336174 ·Status: RECRUITING
-
Safety Study of MT-4666 in Subjects With Alzheimer's Disease
NCT02327182 ·Status: TERMINATED ·Phase: PHASE3